Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells

Transfusion

Volumn 46, Issue 9, 2006, Pages 1526-1536

  Hendrickson, Jeanne E ^b   Desmarets, Maxime ^b   Deshpande, Seema S ^b   Chadwick, Traci E ^b   Hillyer, Christopher D ^b   Roback, John D ^b   Zimring, James C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; BLOOD GROUP ANTIGEN; DOUBLE STRANDED RNA; LYSOZYME; POLYINOSINIC POLYCYTIDYLIC ACID;

ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFLAMMATION; MOUSE; NONHUMAN; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; CROSSES, GENETIC; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; IMMUNIZATION; IMMUNOGLOBULIN G; INFLAMMATION; ISOANTIGENS; LEUKOCYTE REDUCTION PROCEDURES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; MODELS, ANIMAL; MURAMIDASE; POLY I-C;

EID: 33748331170     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00946.x     Document Type: Article

References (51)

1. Reid ME, Westoff WM. Red blood cells. In: Hillyer CD, Silberstein LE, Ness PM, Anderson KC, editors. Blood banking and transfusion medicine: basic principles and practice. Philadelphia: Churchill Livingstone; 2003. p. 11-61.
2. Petz LD, Swisher SN, Kleinman S, et al, editors. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone; 1996.
3. Heddle NM, Soutar RL, O'Hoski PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995;911000-5.
4. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42-5.
5. Seyfried H, Walewska I. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Materia Med Polona 1990;22:21-5.
6. Cook IA. Primary rhesus immunization of male volunteers. Br J Haematol 1971;20:369-75.
7. Freda VJ, Gorman JG, Pollack W, et al. Prevention of Rh isoimmunization: progress report of the clinical trial in mothers. JAMA 1967;199:390-4.
8. Gunson HH, Stratton F, Cooper DG, Rawlinson VI. Primary immunization of Rh-negative volunteers. Br Med J 1970;1:593-5.
9. Hattersley P. Two popular fallacies regarding Rh. J Lab Clin Med 1947;32:423.
10. Waller RK. Intentional isoimmunizations against the antigen D(Rho). J Lab Clin Med 1949;34:270.
11. Wiener AS. Further observations on isosensitization to the Rh factor. Proc Soc Exp Biol Med 1949;70:576.
12. Clarke CA, Donohoe WT, McCR, et al. Further experimental studies on the prevention of Rh haemolytic disease. Br Med J 1963;5336:979-84.
13. Frohn C, Dumbgen L, Brand JM, et al. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003;43:893-8.
14. Alarif L, Castro O, Ofosu M, et al. HLA-B35 is associated with red cell alloimmunization in sickle cell disease. Clin Immunol Immunopathol 1986;38:178-83.
15. Ansart-Pirenne H, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens based on HLA Class II restriction analysis.Blood 2005;106:130a.
16. Brantley SG, Ramsey G. Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion 1988;28:463-6.
17. Azar MM, Wyche AA. Route of antigen administration for tolerance production. Life Sci 1974;14:2151-7.
18. Endres RO, Grey HM. Antigen recognition by T cells. II. Intravenous administration of native or denatured ovalbumin results in tolerance to both forms of the antigen. J Immunol 1980;125:1521-5.
19. Weigle WO. Immunological unresponsiveness. Adv Immunol 1973;16:61-122.
20. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-5.
21. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
22. Imler JL, Hoffmann JA. Toll and Toll-like proteins: an ancient family of receptors signaling infection. Rev Immunogenet 2000;2:294-304.
23. Murillo LS, Morre SA, Pena AS. Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response. Drugs Today 2003;39:415-38.
24. Modlin RL. Mammalian toll-like receptors. Ann Allergy Asthma Immunol 2002;88:543-7.
25. Blumberg N, Peck K, Ross K, Avila E. Immune response to chronic red blood cell transfusion. Vox Sang 1983;44:212-7.
26. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431-7.
27. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37-43.
28. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997;37:357-61.
29. Jison ML, Munson PJ, Barb JJ, et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 2004;104:270-80.
30. Chies JA, Nardi NB. Sickle cell disease: a chronic inflammatory condition. Med Hypotheses 2001;57:46-50.
31. Belcher JD, Bryant CJ, Nguyen J, et al. Transgenic sickle mice have vascular inflammation. Blood 2003;101:3953-9.
32. Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med 2005;230:68-74.
33. Zimring JC, Hair G, Chadwick TE, et al. Non-hemolytic antibody-induced loss erythrocyte surface antigen. Blood 2005;106:1105-12.
34. Dijkstra-Tiekstra MJ, Schrijver JG, van der Meer PF, et al. Crossover study of three methods for low-level white blood cell counting on two types of flow cytometer. Cytometry B Clin Cytom 2003;54:39-45.
35. de Isla NG, Riquelme BD, Rasia RJ, et al. Quantification of glycophorin A and glycophorin B on normal human RBCs by flow cytometry. Transfusion 2003;43:1145-52.
36. Poncelet P, Carayon P. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J Immunol Methods 1985;85:65-74.
37. Wagner T, Kormoczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion 2005;45:520-6.
38. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699-708.
39. Everds N. Hematology of the mouse. In: Hedrich HJ, editor. The laboratory mouse. London: Elsevier/Academic Press; 2004. p. 271-86.
40. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996;219:339-49.
41. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
42. Campell Lee SA, Liu J, Shirey RS, et al. The production of anti-Fyb in mice transfused with blood from Fyb expressing transgenic mice. Transfusion 2004;44(9 Suppl):32A.
43. Krevans JR, Woodrow JC, Nosenzo C, Finn R. Patterns of Rh immunization. 10th Congress of the International Society of Haematology; 1964; Stockholm.
44. Woodrow JC Finn R Krevans JR. Rapid clearance of Rh positive blood during experimental Rh immunisation. Vox Sang 1969;17:349-61.
45. Gelman AE Zhang J Choi Y Turka LA. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 2004;172:6065-73.
46. Sivori S Falco M Della Chiesa M, et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 2004;101:10116-21.
47. Wilder JA, Koh CY, Yuan D. The role of NK cells during in vivo antigen-specific antibody responses. J Immunol 1996;156:146-52.
48. Sayeh E, Sterling K, Speck E, et al. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells. Blood 2004;103:2705-9.
49. Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44:16-24.
50. King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004;44:25-9.
51. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003;43:945-52.